The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000990325
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
25/07/2026
Date registered
Help: Date registered
12/08/2026
Date last updated
Help: Date last updated
12/08/2026
Date data sharing statement initially provided
Help: Data sharing statement date
12/08/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Virtual Patients to train Regional Anaesthesia Informed Consent using Generative AI (The VIRTUE-RA study)
Scientific title
The impact of generative AI virtual patient simulation on teaching informed consent for regional anaesthesia in junior anaesthesics trainees and their performance
Additional trial identifiers [1] 317908 0
Nil known
Universal Trial Number (UTN)
Trial acronym
VIRTUE-RA
Related trial records

Health condition
Health condition(s) studied:
Regional anaesthesia 342920 0
Condition category
Condition code
Anaesthesiology 339038 339038 0 0
Other anaesthesiology

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The training exposure is delivered using SimChatTM, a commercial video-based GenAI-powered virtual patient system. Trainees will conversationally interact with AI avatars who automatically respond after each input. Trainees will attempt to obtain informed consent for regional anaesthesia in each case, which involves disclosing risks, benefits, and alternative options for that particular patient’s context. The system has adaptive dialogue that allows each interaction to be unique and evolves according to the questions and answers provided in real-time.
We will program ten RA-relevant patient histories with real-life clinical features into the system. They will have different personality traits and cultural backgrounds, to provide the platform with a realistic range of patient presentations relevant for RA. A minimum of two sessions will be completed by each trainee within a 60 min training period. This training period will only occur once. Adherence to training is live monitored by investigators, and also recorded within SimChat as transcripts and user statistics on number of AI profiles completed.
At each recruitment site, equipment can be a personal computer or tablet with microphone and speaker enabled to allow speaking and listening of the conversation. Thus, participants speak into the microphone, the AI will respond, enabling free conversation. At the end of every session, SimChat’s will provide automated feedback according to the Objective Structured Clinical Examination (OSCE) format used throughout the study. At the end of the 60min, a debrief session will also be conducted by faculty to provide further feedback, and respond to any questions.
Intervention code [1] 334779 0
Treatment: Devices
Description of the comparator or control
Both immediately before and after the AI-training intervention, participants will view different video vignettes of patients who require counselling for regional anaesthesia. Participants will be required to role-play obtaining informed consent in each case, and their responses are scored using the aforementioned OSCE tool. The two assessors will be blinded to participant identities and whether the intervention was pre- or post-training.

Thus, each participant's pre-training OSCE scores can be compared to their post-training scores.
Control group
Active

Outcomes
Primary outcome [1] 346282 0
Change in trainee performance in obtaining informed consent for regional anaesthesia
Timepoint [1] 346282 0
Immediately pre-training (baseline), immediately post-training
Secondary outcome [1] 465306 0
Agreement between human-assessed versus GenAI-assessed scoring
Timepoint [1] 465306 0
Both GenAI and human assessment will occur during training
Secondary outcome [2] 465307 0
Relevance of cases, satisfaction, and acceptability of the proposed GenAI intervention by trainees. They will all be assessed as a composite outcome.
Timepoint [2] 465307 0
Immediately post-training
Secondary outcome [3] 465308 0
Workplace-based assessment of informed consent communication skills of trainees in clinical context
Timepoint [3] 465308 0
Within 1 month of AI-training

Eligibility
Key inclusion criteria
First year junior anaesthetic trainees
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
If a trainee was previously involved in Phase 1 (pilot), they are excluded from
participation in Phase 2 (definitive).

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
In the study of communication skills using standardised patients and scored by OSCE, a small Cohen’s d=0.40 was reported for the intervention arm. In contrast, a larger Cohen’s d=0.79 was reported for medical students learning informed consent. For the primary outcome, and assuming a mean change equivalent to a small Cohen’s d effect size (d=0.4), using a two sided t test, power 0.80 and alpha = 0.05, a sample size of 40 trainees per group is required. OSCE scores are graded as a percentage, and this moderate effect size is equivalent to a 5% change in scoring. Allowing for drop outs and withdrawals, we will increase the sample size to 45 participants in the definitive trial. This number will be confirmed after analysing results of the pilot study (phase 1).
For the pilot study of 15 participants, we chose the lower end of reported results given the large range of effect sizes, and will verify after completing it.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,WA
Recruitment hospital [1] 29882 0
Liverpool Hospital - Liverpool
Recruitment hospital [2] 29947 0
Prince of Wales Hospital - Randwick
Recruitment hospital [3] 29948 0
Rockingham General Hospital - Cooloongup
Recruitment postcode(s) [1] 46239 0
2170 - Liverpool
Recruitment postcode(s) [2] 46310 0
2031 - Randwick
Recruitment postcode(s) [3] 46311 0
6168 - Cooloongup
Recruitment outside Australia
Country [1] 28356 0
United States of America
State/province [1] 28356 0
Country [2] 28357 0
United Kingdom
State/province [2] 28357 0
Country [3] 28358 0
Ukraine
State/province [3] 28358 0
Country [4] 28359 0
Hong Kong
State/province [4] 28359 0
Country [5] 28360 0
New Zealand
State/province [5] 28360 0
Country [6] 28402 0
Greece
State/province [6] 28402 0

Funding & Sponsors
Funding source category [1] 322443 0
University
Name [1] 322443 0
University of New South Wales
Country [1] 322443 0
Australia
Primary sponsor type
University
Name
University of New South Wales
Address
Country
Australia
Secondary sponsor category [1] 325369 0
None
Name [1] 325369 0
Address [1] 325369 0
Country [1] 325369 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320935 0
The University of New South Wales Research Ethics Committee A
Ethics committee address [1] 320935 0
Ethics committee country [1] 320935 0
Australia
Date submitted for ethics approval [1] 320935 0
22/06/2026
Approval date [1] 320935 0
29/06/2026
Ethics approval number [1] 320935 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 152134 0
Prof Alwin Chuan
Address 152134 0
Liverpool Hospital, Corner of Elizabeth and Goulburn Streets, LIVERPOOL NSW 2170
Country 152134 0
Australia
Phone 152134 0
+61 2 8738 8582
Fax 152134 0
Email 152134 0
Contact person for public queries
Name 152135 0
Alwin Chuan
Address 152135 0
Liverpool Hospital, Corner of Elizabeth and Goulburn Streets, LIVERPOOL NSW 2170
Country 152135 0
Australia
Phone 152135 0
+61 2 8738 8582
Fax 152135 0
Email 152135 0
Contact person for scientific queries
Name 152136 0
Alwin Chuan
Address 152136 0
Liverpool Hospital, Corner of Elizabeth and Goulburn Streets, LIVERPOOL NSW 2170
Country 152136 0
Australia
Phone 152136 0
+61 2 8738 8582
Fax 152136 0
Email 152136 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.